Effect of religiosity/spirituality on ovarian cancer diagnosis in African American women

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAn examination of data from a multi-center case-control study of ovarian cancer in African American women found that women who re

Updated on: April 01,2024

Effect of religiosity/spirituality on ovarian cancer diagnosis in African American women

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAn examination of data from a multi-center case-control study of ovarian cancer in African American women found that women who re

Updated on:April 01,2024

Cancer patients diagnosed early are more likely to avoid chemotherapy

by Cancer Research UKCredit: Cancer Research UKCancer patients are around five times more likely to have surgery to remove their tumour, and less likely to have chemotherapy, if they are diagnose

Updated on: April 20,2024

Cancer patients diagnosed early are more likely to avoid chemotherapy

by Cancer Research UKCredit: Cancer Research UKCancer patients are around five times more likely to have surgery to remove their tumour, and less likely to have chemotherapy, if they are diagnose

Updated on:April 20,2024

Palliative care in breast cancer treatment may be less likely for racial/ethnic minority patients than white patients

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainDespite a steady increase in palliative care utilization from 2004 to 2020, non-Hispanic Black, Hispanic, and Asian or

Updated on: May 07,2024

Palliative care in breast cancer treatment may be less likely for racial/ethnic minority patients than white patients

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainDespite a steady increase in palliative care utilization from 2004 to 2020, non-Hispanic Black, Hispanic, and Asian or

Updated on:May 07,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on: January 30,2024

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on:January 30,2024

Tumors backfire on chemotherapy

by Ecole Polytechnique Federale de LausanneEndothelial cells (blue/grey) internalizing exosomes (red) released from chemotherapy-treated tumors. Credit: C. Cianciaruso/I. Keklikoglou/EPFLSome pat

Updated on: April 07,2024

Tumors backfire on chemotherapy

by Ecole Polytechnique Federale de LausanneEndothelial cells (blue/grey) internalizing exosomes (red) released from chemotherapy-treated tumors. Credit: C. Cianciaruso/I. Keklikoglou/EPFLSome pat

Updated on:April 07,2024

New precision therapy for bile duct cancer extends patients' lives

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international

Updated on: January 12,2024

New precision therapy for bile duct cancer extends patients' lives

byUniversity College LondonCredit: Pixabay/CC0 Public DomainA new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international

Updated on:January 12,2024

Rural residence tied to poorer adherence to radiation treatment for cancer

Rural residence is associated with both radiation treatment (RT) nonadherence and poorer overall survival among cancer patients, according to a study recently published in theInternational Journ

Updated on: January 02,2024

Rural residence tied to poorer adherence to radiation treatment for cancer

Rural residence is associated with both radiation treatment (RT) nonadherence and poorer overall survival among cancer patients, according to a study recently published in theInternational Journ

Updated on:January 02,2024

Social media can boost melanoma detection, research suggests

by Leila Okahata,University of OregonExamples of knowledge, self-efficacy, and control messages. Credit:JID Innovations(2023). DOI: 10.1016/j.xjidi.2023.100253Early detection is key

Updated on: March 30,2024

Social media can boost melanoma detection, research suggests

by Leila Okahata,University of OregonExamples of knowledge, self-efficacy, and control messages. Credit:JID Innovations(2023). DOI: 10.1016/j.xjidi.2023.100253Early detection is key

Updated on:March 30,2024

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Updated on: February 03,2024

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Updated on:February 03,2024

Startup helps identify patients at risk for hereditary cancers

by Greta Guest,University of MichiganCredit: CC0 Public DomainUniversity of Michigan startup InheRET Inc. has launched an online program that helps identify patients at risk for hereditary cance

Updated on: March 08,2024

Startup helps identify patients at risk for hereditary cancers

by Greta Guest,University of MichiganCredit: CC0 Public DomainUniversity of Michigan startup InheRET Inc. has launched an online program that helps identify patients at risk for hereditary cance

Updated on:March 08,2024

Tumor-specific therapy targets ovarian cancer

by Anna Zarra Aldrich,University of ConnecticutUConn professor Xiuling Lu with members of her lab team at the School of Pharmacy on Nov. 8, 2018. Credit: (Sean Flynn/UConn Photo)Nami Therapeutic

Updated on: April 09,2024

Tumor-specific therapy targets ovarian cancer

by Anna Zarra Aldrich,University of ConnecticutUConn professor Xiuling Lu with members of her lab team at the School of Pharmacy on Nov. 8, 2018. Credit: (Sean Flynn/UConn Photo)Nami Therapeutic

Updated on:April 09,2024

A novel strategy to suppress triple negative breast cancer growth

by Homa Shalchi,Baylor College of MedicineCredit:PLOS Biology(2023). DOI: 10.1371/journal.pbio.3002227In 2022, a team of researchers at Baylor College of Medicinediscovered&nbs

Updated on: February 01,2024

A novel strategy to suppress triple negative breast cancer growth

by Homa Shalchi,Baylor College of MedicineCredit:PLOS Biology(2023). DOI: 10.1371/journal.pbio.3002227In 2022, a team of researchers at Baylor College of Medicinediscovered&nbs

Updated on:February 01,2024